LS Investment Advisors’s Surmodics SRDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-450
Closed -$19K 1366
2020
Q2
$19K Hold
450
﹤0.01% 1412
2020
Q1
$15K Hold
450
﹤0.01% 1458
2019
Q4
$19K Sell
450
-1,026
-70% -$43.2K ﹤0.01% 1548
2019
Q3
$68K Hold
1,476
﹤0.01% 1206
2019
Q2
$64K Hold
1,476
﹤0.01% 1235
2019
Q1
$64K Buy
1,476
+513
+53% +$26.1K ﹤0.01% 1238
2018
Q4
$46K Sell
963
-542
-36% -$32.5K ﹤0.01% 1292
2018
Q3
$112K Sell
1,505
-414
-22% -$28.5K 0.01% 1083
2018
Q2
$106K Sell
1,919
-70
-4% -$3.23K 0.01% 1124
2018
Q1
$76K Hold
1,989
﹤0.01% 1182
2017
Q4
$56K Buy
1,989
+182
+10% +$5.55K ﹤0.01% 1278
2017
Q3
$56K Buy
1,807
+537
+42% +$14.6K ﹤0.01% 1316
2017
Q2
$36K Hold
1,270
﹤0.01% 1443
2017
Q1
$31K Buy
+1,270
New +$31.1K ﹤0.01% 1468

Other funds holding SRDX

LS Investment Advisors's SRDX Position: Q3 2020 in Review

LS Investment Advisors sold out of Surmodics (SRDX) in Q3 2020, closing a stake of 450 shares — an estimated $19K sold.

LS Investment Advisors first reported a position in SRDX in Q1 2017 and held it in 14 quarters. The position peaked at $112K in Q3 2018. 141 funds tracked by Wall St. Rank hold SRDX as of Q3 2020.

  • LS Investment Advisors reported no remaining Surmodics position as of Q3 2020 after selling out during the quarter.
  • LS Investment Advisors sold 450 Surmodics shares in Q3 2020, an estimated $19K.
  • LS Investment Advisors first reported a position in Surmodics in Q1 2017 and held it in 14 quarters.
  • LS Investment Advisors's Surmodics position peaked at $112K in Q3 2018.
  • 141 funds tracked by Wall St. Rank held Surmodics as of Q3 2020.

Based on LS Investment Advisors's 13F filing for Q3 2020, filed 12 Nov 2020.